ENTRY       D07455                      Drug
NAME        Anagrelide (INN/BAN)
FORMULA     C10H7Cl2N3O
EXACT_MASS  254.9966
MOL_WEIGHT  256.0881
CLASS       Cardiovascular agent
             DG01507  Phosphodiesterase III inhibitor
            Metabolizing enzyme substrate
             DG01891  CYP1A1 substrate
             DG01892  CYP1A2 substrate
REMARK      ATC code: L01XX35
            Chemical structure group: DG00727
            Product (DG00727): D10255<JP/US>
EFFICACY    Thrombocythemia treatment, Platelet aggregation inhibitor, Phosphodiesterase inhibitor
TARGET      PDE3 [HSA:5139 5140] [KO:K19021 K13296]
  PATHWAY   hsa00230(5139+5140)  Purine metabolism
METABOLISM  Enzyme: CYP1A1 [HSA:1543], CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX35 Anagrelide
                  D07455  Anagrelide (INN/BAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01507  Phosphodiesterase III inhibitor
               DG00727  Anagrelide
                D07455  Anagrelide
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               DG00727  Anagrelide
                D07455  Anagrelide
              DG01892  CYP1A2 substrate
               DG00727  Anagrelide
                D07455  Anagrelide
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphodiesterases
                PDE3
                 D07455  Anagrelide (INN/BAN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07455
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07455
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01507  Phosphodiesterase III inhibitor
               DG00727  Anagrelide
             Metabolizing enzyme substrate
              DG01891  CYP1A1 substrate
               DG00727  Anagrelide
              DG01892  CYP1A2 substrate
               DG00727  Anagrelide
DBLINKS     CAS: 68475-42-3
            PubChem: 51091786
            ChEBI: 142290
            PDB-CCD: J33
            LigandBox: D07455
            NIKKAJI: J18.596E
ATOM        16
            1   N1y N    23.8000  -17.9200
            2   C2y C    23.8000  -19.3200
            3   N2x N    22.6100  -20.0200
            4   C8y C    21.3500  -19.3200
            5   C8y C    21.3500  -17.9200
            6   C1x C    22.5400  -17.2200
            7   C8y C    20.1600  -17.2200
            8   C8y C    18.9000  -17.9200
            9   C8x C    18.9000  -19.3200
            10  C8x C    20.1600  -20.0200
            11  X   Cl   20.1600  -15.8200
            12  X   Cl   17.7100  -17.2200
            13  N1x N    25.1300  -19.7400
            14  C5x C    25.9000  -18.6200
            15  C1x C    25.1300  -17.5000
            16  O5x O    27.3000  -18.6200
BOND        18
            1     2   3 2
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     6   1 1
            6     1   2 1
            7     5   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11   10   4 1
            12    7  11 1
            13    8  12 1
            14    2  13 1
            15   13  14 1
            16   14  15 1
            17    1  15 1
            18   14  16 2
///
